|
Surgical
|
Indicators
|
Benchmark referral values
|
|---|
|
Procedure
| |
Present study
|
International
literature
|
|---|
|
WE
|
Wound infection
|
1.1% (0.4 to 2.7%)
|
4.6–8.4%a
|
|
Wound dehiscence
|
2.0% (0.8 to 5.1%)
|
3.5–4.6%a
|
|
Skin graft failure
|
unreliable
|
< 2%a
|
|
SLNB
|
Wound Infection
|
1.3% (0.7 to 2.5%)
|
2.9% (1.5 to 4.6%)b
|
|
Wound dehiscence
|
0.9% (0.2 to 3.0%)
|
0.24–1.2%a
|
|
Seroma
|
4.2% (1.5 to 11.1%)
|
5.1% (2.5 to 8.6%)b
|
|
LFND
|
Wound infection
|
4.1% (2.1 to 8.0%)
|
15.8%a
|
|
Wound dehiscence
|
2.8% (0.9 to 8.6%)
|
3%a
|
|
Wound infection and/or dehiscence
|
6.5% (2.9 to 14.0%)
|
21.6% (13.8 to 30.6%)c
|
|
Seroma
|
15.1% (4.6 to 39.9%)
|
17.9% (10.3 to 27%)c
|
- Data expressed as percentage with 95% confidence interval in parentheses
- aMorton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005 Sep;242 (3):302–11; discussion 311–3
- bMoody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma-A systematic review of the literature. Eur J Surg Oncol. 2017;43:270–277
- cMoody JA, Botham SJ, Dahill KE, Wallace DL, Hardwicke JT. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature. Eur J Surg Oncol. 2017;43:1760–1767
